- Home
- IPSC vs REE Comparison
IPSC vs REE Comparison
Compare IPSC & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- REE
- Stock Information
- Founded
- IPSC 2019
- REE 2011
- Country
- IPSC United States
- REE Israel
- Employees
- IPSC 165
- REE N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- REE Auto Manufacturing
- Sector
- IPSC Health Care
- REE Consumer Discretionary
- Exchange
- IPSC Nasdaq
- REE Nasdaq
- Market Cap
- IPSC 146.2M
- REE 135.8M
- IPO Year
- IPSC 2021
- REE N/A
- Fundamental
- Price
- IPSC $1.57
- REE $7.90
- Analyst Decision
- IPSC Strong Buy
- REE Buy
- Analyst Count
- IPSC 4
- REE 4
- Target Price
- IPSC $13.00
- REE $9.25
- AVG Volume (30 Days)
- IPSC 579.3K
- REE 47.3K
- Earning Date
- IPSC 11-05-2024
- REE 12-17-2024
- Dividend Yield
- IPSC N/A
- REE N/A
- EPS Growth
- IPSC N/A
- REE N/A
- EPS
- IPSC N/A
- REE N/A
- Revenue
- IPSC $2,684,000.00
- REE $825,000.00
- Revenue This Year
- IPSC $244.52
- REE N/A
- Revenue Next Year
- IPSC $27.73
- REE $50,620.25
- P/E Ratio
- IPSC N/A
- REE N/A
- Revenue Growth
- IPSC 7.88
- REE N/A
- 52 Week Low
- IPSC $1.14
- REE $2.91
- 52 Week High
- IPSC $5.51
- REE $8.79
- Technical
- Relative Strength Index (RSI)
- IPSC 60.84
- REE 58.22
- Support Level
- IPSC $1.20
- REE $7.51
- Resistance Level
- IPSC $1.83
- REE $8.20
- Average True Range (ATR)
- IPSC 0.14
- REE 0.59
- MACD
- IPSC 0.05
- REE 0.06
- Stochastic Oscillator
- IPSC 66.35
- REE 66.79
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.